US Sues AmerisourceBergen Claiming Suspicious Opioid Orders
- US claims the company failed to properly report orders to DEA
- The government is seeking injunction, billions in civil fines
An officer from the US Customs and Border Protection finds Oxycodone pills at John F. Kennedy Airport in New York.
Photographer: Johannes Eisele/AFP/Getty ImagesThis article is for subscribers only.
AmerisourceBergen Corp. was sued by the US for allegedly contributing to the opioid epidemic by failing to report suspicious orders for controlled substances since 2014.
The drug distributor “repeatedly refused or negligently failed to report suspicious orders placed by pharmacy customers that defendants had reason to know were allowing opioids and other controlled substances to be diverted into illegal channels,” the government said in a civil complaint filed Thursday in federal court in Philadelphia.